Impact of Sacubitril–Valsartan Treatment on Diastolic Function and Right Ventricular Function in Patient with Heart Failure with Reduced Ejection Fraction

Impact of Sacubatril/Valsartan on Myocardial and Hepatic Stiffness in Heart Failure patients with Reduced Ejection Fraction (HFrEF)

Safety and Efficacy of Sacubitril ̸ Valsartan drug in Heart Failure Patients

Efficacy and safety of (Sacubitril-Valsartan) Combination on Patients With congestive Heart Failure

Effect of eplerenon on heart failure in patients with paroxysmal Atrial Fibrillation and ejection fraction ≥ 45%.

Еffеct of Sacubіtrіl/Valsartan on Kіdnеy Functіon іn Hеart Faіlurе Patіеnts wіth Rеducеd Еjеctіon Fractіon

Safety and Efficacy of Sacubitril/Valsartan Early Initiation in Hospitalized Patients with Heart Failure and Reduced Ejection Fraction

IMPACT OF CARDIAC REHABILITATION ON PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION

EFFECT OF MODERN VERSUS STANDARD OF CARE ANTI-FAILURE MEDICATIONS ON LEFT VENTRICULAR FUNCTION IN HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION AS DETECTED BY2D SPECKLE TR

Unlocking Heart Failure's Secret Weapon: The Transformative Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Heart Failure with Reduced Ejection Fraction